Building a Healthy China is a key goal in the Outline of the 14th Five-Year Plan for National Economic and Social Development and the Long-Range Objectives Through the Year 2035. This session discussed the Healthy China initiative and new opportunities arising from it.

The panelists shared the same view on the general direction of the initiative, which will support the foundation and building of a Healthy China through innovation, and play afundamental role in socialist modernization.

Addressing the development of innovation reforms, Albert Bourla, Chairman & CEO of Pfizer Inc., Christophe Weber, President & CEO of Takeda Pharmaceutical Company, and Milind Pant, CEO of Amway Corporation, agreed that international cooperation and exchange will be of great help in building a Healthy China. Zhang Jianqiu, CEO of Inner Mongolia Yili Industrial Group Co., pointed out that innovation reforms require the integration of product models, operating models and digital applications. Overall, panelists from the enterprise side put greater emphasis on development through business cooperation, business transformation and innovation.

Download the full report：New Opportunities in the Healthy China Initiative